Cargando…

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis

BACKGROUND: Hypoxia-inducible factor prolyl hydroxylase inhibitors such as vadadustat may provide an oral alternative to injectable erythropoiesis-stimulating agents for treating anemia in patients receiving peritoneal dialysis. In two randomized (1:1), global, phase 3, open-label, sponsor-blind, pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarnak, Mark J, Agarwal, Rajiv, Boudville, Neil, Chowdhury, Pradip C P, Eckardt, Kai-Uwe, Gonzalez, Carlos R, Kooienga, Laura A, Koury, Mark J, Ntoso, Kwabena A, Luo, Wenli, Parfrey, Patrick S, Vargo, Dennis L, Winkelmayer, Wolfgang C, Zhang, Zhiqun, Chertow, Glenn M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539221/ https://www.ncbi.nlm.nih.gov/pubmed/37096396 http://dx.doi.org/10.1093/ndt/gfad074

Ejemplares similares

Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
por: Agarwal, Rajiv, et al.
Publicado: (2023)

Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO(2)VATE trials
por: Eckardt, Kai-Uwe, et al.
Publicado: (2020)

Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
por: Koury, Mark J., et al.
Publicado: (2022)

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO(2)TECT Randomized Clinical Trial of ESA-Treated Patients
por: Parfrey, Patrick S., et al.
Publicado: (2023)

Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO(2)TECT Randomized Clinical Trial of ESA-Naïve Patients
por: Winkelmayer, Wolfgang C., et al.
Publicado: (2023)

Vadadustat for anemia in chronic kidney disease patients on peritoneal dialysis: A phase 3 open‐label study in Japan
por: Nangaku, Masaomi, et al.
Publicado: (2020)

Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions
por: Erickson, Kevin F., et al.
Publicado: (2019)

Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
por: Haase, Volker H, et al.
Publicado: (2019)

Association of Peritonitis With Cardiovascular Mortality Over Time in the Peritoneal Dialysis Population: An Australia and New Zealand Dialysis and Transplant Registry Study
por: Cheikh Hassan, Hicham I., et al.
Publicado: (2022)

Risk factors of short-term mortality after acute nonvariceal upper gastrointestinal bleeding in patients on dialysis: a population-based study
por: Yang, Ju-Yeh, et al.
Publicado: (2013)

Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study
por: Ziolkowski, Susan, et al.
Publicado: (2022)

Thienopyridine Use After Coronary Stenting in Low Income Patients Enrolled in Medicare Part D Receiving Maintenance Dialysis
por: Chang, Tara I., et al.
Publicado: (2014)

Incremental Versus Standard (Full-Dose) Peritoneal Dialysis
por: Cheetham, Melissa S., et al.
Publicado: (2021)

Hookworm Anemia in a Peritoneal Dialysis Patient in China
por: Wu, Fuquan, et al.
Publicado: (2016)

Efficacy and Safety of Vadadustat for Anemia in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Xiong, Limei, et al.
Publicado: (2022)

And Then There Were Three: Effects of Pretransplant Dialysis on Multiorgan Transplantation
por: Cheng, Xingxing S., et al.
Publicado: (2021)

Association between causes of peritoneal dialysis technique failure and all-cause mortality
por: Chen, Jenny H. C., et al.
Publicado: (2018)

Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
por: Hirai, Keiji, et al.
Publicado: (2021)

Anemia Management in Peritoneal Dialysis: Perspectives From the Asia Pacific Region
por: Li, Philip Kam Tao, et al.
Publicado: (2021)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Impact of gender and dialysis adequacy on anaemia in peritoneal dialysis
por: Ryta, Alicja, et al.
Publicado: (2017)

Hemodialysis Versus Peritoneal Dialysis Drug Expenditures: A Comparison Within the Private Insurance Market
por: Bhatnagar, Anshul, et al.
Publicado: (2023)

Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients
por: Huang, Jeng-Yi, et al.
Publicado: (2016)

Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis
por: Wu, Tong, et al.
Publicado: (2022)

Roxadustat for CKD-related Anemia in Non-dialysis Patients
por: Coyne, Daniel W., et al.
Publicado: (2020)

Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis
por: Akizawa, Tadao, et al.
Publicado: (2021)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis
por: Provenzano, Robert, et al.
Publicado: (2020)

Calcium balance in peritoneal dialysis patients treated by continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) cyclers
por: Davenport, Andrew
Publicado: (2023)

Laparoscopic Placement of Peritoneal Dialysis Catheter (Same Day Dialysis)
por: Al-Dohayan, Abdullah
Publicado: (1999)

Association between Dialysis Adequacy and Cognition in Patients with Peritoneal Dialysis
por: Shin, Dong Jin, et al.
Publicado: (2020)

Pre-ESKD Nephrology Care and Employment at the Start of Dialysis
por: Awan, Ahmed A., et al.
Publicado: (2020)

Rhabdomyolysis caused by interaction between rosuvastatin and vadadustat: a case report
por: Sakurama, Keiki, et al.
Publicado: (2023)

Peritoneal dialysis in Peru
por: Vélez-Segovia, E., et al.
Publicado: (2014)

Psychiatrist and Peritoneal Dialysis
por: Klarić, D., et al.
Publicado: (2022)

Peritoneal dialysis: why not?
por: Andreoli, Maria Claudia Cruz, et al.
Publicado: (2023)

Prescribing and peritoneal dialysis
por: Reimann, Frank, et al.
Publicado: (2023)

Tidal continuous cycling peritoneal dialysis in children
por: Butani, Lavjay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s4q35k4c812v06lb08s8cfg7i1